Andorra vs Cayman Islands: Tuberculosis patients living with HIV receiving antiretroviral therapy
Andorra
0 patients
in 2021
Cayman Islands
0 patients
in 2020
Andorra rank
141st
Cayman Islands rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Andorra
- Cayman Islands
How they compare
Andorra currently reports 0 patients against 0 patients in Cayman Islands, a difference of 0 patients.
Across all 13 years both countries report, Cayman Islands has been ahead every year.
Andorra ranks 141st and Cayman Islands ranks 141st of 183 countries.
Head to head by decade
| Decade | Andorra | Cayman Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 0.1111 patients | 0.1111 patients | 0 patients | — |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Andorra or Cayman Islands?
- Andorra, at 0 patients against 0 patients in Cayman Islands as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Andorra and Cayman Islands?
- 0 patients, with Andorra ahead.
- How many years of comparable data are there for Andorra and Cayman Islands?
- 13 years are reported by both, from 2003 to 2020.
- How do Andorra and Cayman Islands rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Andorra ranks 141st and Cayman Islands ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.